Results 151 to 160 of about 1,378,916 (231)

INDUCTION AND/OR MAINTENANCE OF TUMOR DORMANCY BY DISRUPTION OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-INTEGRIN INTERACTION

open access: yes, 2010
The present invention relates to a method of inducing cancer cells into dormancy and treating cancer in a subject. This method involves administering to a subject an effective amount of a compound that disrupts interaction between urokinase plasminogen ...
Aguirre-Ghiso Julio, A   +4 more
core  

Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis. [PDF]

open access: yesKidney Dis (Basel), 2019
Sun P   +6 more
europepmc   +1 more source

Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating alpha(v)beta5 vitronectin receptor cell surface expression

open access: yes, 2002
We have previously shown that urokinase receptor physically and functionally interacts with alpha(v)beta5 vitronectin receptor, leading to tumor breast cell migration and invasion.
Longanesi Cattani I   +6 more
core  

Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer. [PDF]

open access: yesAntibodies (Basel), 2019
Harel ET   +12 more
europepmc   +1 more source

Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release. [PDF]

open access: yesTheranostics, 2019
Li S   +11 more
europepmc   +1 more source

Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity. [PDF]

open access: yesSci Rep, 2019
Minopoli M   +9 more
europepmc   +1 more source

Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children. [PDF]

open access: yesJAMA Pediatr, 2017
Schaefer F   +28 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy